VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,983 | -10.6% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $39,143 | -6.9% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,055 | +10.7% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $38,000 | -51.9% | 1,300 | -60.6% | 0.00% | -50.0% |
| Q3 2022 | $79,000 | +54.9% | 3,300 | +73.7% | 0.00% | +100.0% |
| Q2 2022 | $51,000 | +2.0% | 1,900 | +46.2% | 0.00% | 0.0% |
| Q1 2022 | $50,000 | +19.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | +10.5% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | -19.1% | 1,300 | -7.1% | 0.00% | 0.0% |
| Q2 2021 | $47,000 | +4.4% | 1,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | -84.6% | 1,400 | -82.7% | 0.00% | -87.5% |
| Q4 2020 | $292,000 | -29.6% | 8,100 | -23.6% | 0.01% | -33.3% |
| Q3 2020 | $415,000 | +6.7% | 10,596 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $389,000 | +18.2% | 10,596 | -25.9% | 0.01% | -7.1% |
| Q1 2020 | $329,000 | +100.6% | 14,296 | +155.5% | 0.01% | +133.3% |
| Q4 2019 | $164,000 | -24.8% | 5,596 | -31.3% | 0.01% | -33.3% |
| Q3 2019 | $218,000 | +137.0% | 8,146 | +126.5% | 0.01% | +125.0% |
| Q2 2019 | $92,000 | +318.2% | 3,596 | +259.6% | 0.00% | +300.0% |
| Q1 2019 | $22,000 | +4.8% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $21,000 | -12.5% | 1,000 | -21.9% | 0.00% | 0.0% |
| Q3 2018 | $24,000 | -14.3% | 1,280 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $28,000 | -84.3% | 1,280 | -84.3% | 0.00% | -83.3% |
| Q1 2018 | $178,000 | -65.4% | 8,130 | -63.2% | 0.01% | -33.3% |
| Q4 2017 | $514,000 | +103.2% | 22,100 | +100.0% | 0.01% | 0.0% |
| Q3 2017 | $253,000 | -27.1% | 11,050 | -29.6% | 0.01% | -25.0% |
| Q2 2017 | $347,000 | +59.2% | 15,700 | +63.5% | 0.01% | +71.4% |
| Q1 2017 | $218,000 | -76.8% | 9,600 | -78.7% | 0.01% | -75.0% |
| Q4 2016 | $941,000 | -32.9% | 44,990 | -15.2% | 0.03% | -31.7% |
| Q3 2016 | $1,403,000 | -10.3% | 53,040 | -6.0% | 0.04% | -8.9% |
| Q2 2016 | $1,564,000 | – | 56,420 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |